I S Figari

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

C A Dinarello, Joseph G. Cannon, S. M. Wolff et al. · The Journal of Experimental Medicine · 1986 · 1.5K citations · Full text

Life Sciences, Immunology, Pharmacology +12

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Gerald Ranges, I S Figari, Terje Espevik et al. · The Journal of Experimental Medicine · 1987 · 495 citations · Full text

Life Sciences, Cancer Biology, Immunology +17

Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

Louis A. Tartaglia, David V. Goeddel, C. Patrick Reynolds et al. · The Journal of Immunology · 1993 · 291 citations

Life Sciences, Immunology, Cellular Immunology +16

Characterization of the antitumor activities of human tumor necrosis factor-<i>alpha</i> and the comparison with other cytokines: induction of tumor-specific immunity.

Michael A. Palladino, M R Shalaby, Susan M. Kramer et al. · The Journal of Immunology · 1987 · 200 citations

Life Sciences, Immunology, Pharmacology +7

Transforming growth factor- <i>beta</i>  1 (TGF- <i>beta</i>  1) and recombinant human tumor necrosis factor- <i>alpha</i> reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF- <i>beta</i>  1 and TGF- <i>beta</i>  2, and recombinant human TGF- <i>beta</i>  1.

Terje Espevik, I S Figari, Gerald Ranges et al. · The Journal of Immunology · 1988 · 167 citations · Full text

Life Sciences, Immunology, Pharmacology +16